Tenofovir amibufenamide <i>vs</i> tenofovir alafenamide for treating chronic hepatitis B: A real-world study.

World J Gastroenterol · 2023 · PMC10725562 · PMID 38111506

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the ALT normalization rate in the TAF group showed a higher trend compared to the TMF group from baseline to 48 wk, this difference did not reach statistical significance (Figure 3C ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.